This week I speak with Dr. Robert Ang from Vor Biopharma about their innovative approach to treating acute myeloid leukemia (AML). AML is a type of blood cancer that affects the bone marrow, leading to the overgrowth of cancerous cells. Dr. Ang explains that traditional treatments, such as chemotherapy and stem cell transplants, have limitations and risks. Dr. Ang emphasizes the potential of their treatment to revolutionize AML therapy and improve patient outcomes.
Podden och tillhörande omslagsbild på den här sidan tillhör Moira Gunn. Innehållet i podden är skapat av Moira Gunn och inte av, eller tillsammans med, Poddtoppen.
